Search research articles
Contact Us
Filters
Showing results (21-30 of 755) with videos related to
Page
of 76
Sort By:
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 17, 2008
Perspectives on the cyclooxygenase-2/ cyclooxygenase-1 hypothesis
D E Furst
The Journal of Rheumatology
|
February 1, 1991
Defining the toxicity of disease modifying antirheumatic drugs in rheumatoid arthritis
D E Furst
Drugs
|
January 1, 1990
Rational use of disease-modifying antirheumatic drugs
D E Furst
Lancet (London, England)
|
August 30, 2000
Aggressive strategies for treating aggressive rheumatoid arthritis: has the case been proven?
D E Furst
Current Opinion in Rheumatology
|
November 25, 2000
Rational therapy in the treatment of systemic sclerosis
D E Furst
Current Rheumatology Reports
|
December 21, 2000
Oligo- and monoarticular inflammatory arthritis: a need and a hope
D E Furst
The Journal of Rheumatology. Supplement
|
April 1, 1992
Toxicity of antirheumatic medications in children with juvenile arthritis
D E Furst
Annals of the New York Academy of Sciences
|
November 30, 1993
Optimizing combination chemotherapy for rheumatoid arthritis
D E Furst
Pharmacotherapy
|
September 1, 1983
Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis
D E Furst
The Journal of Rheumatology. Supplement
|
October 1, 1988
Clinically important interactions of nonsteroidal antiinflammatory drugs with other medications
D E Furst
Page
of 76
Search research articles
Search
Showing results (21-30 of 755) with videos related to
Sort By:
Page
of 76
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 17, 2008
Perspectives on the cyclooxygenase-2/ cyclooxygenase-1 hypothesis
D E Furst
The Journal of Rheumatology
|
February 1, 1991
Defining the toxicity of disease modifying antirheumatic drugs in rheumatoid arthritis
D E Furst
Drugs
|
January 1, 1990
Rational use of disease-modifying antirheumatic drugs
D E Furst
Lancet (London, England)
|
August 30, 2000
Aggressive strategies for treating aggressive rheumatoid arthritis: has the case been proven?
D E Furst
Current Opinion in Rheumatology
|
November 25, 2000
Rational therapy in the treatment of systemic sclerosis
D E Furst
Current Rheumatology Reports
|
December 21, 2000
Oligo- and monoarticular inflammatory arthritis: a need and a hope
D E Furst
The Journal of Rheumatology. Supplement
|
April 1, 1992
Toxicity of antirheumatic medications in children with juvenile arthritis
D E Furst
Annals of the New York Academy of Sciences
|
November 30, 1993
Optimizing combination chemotherapy for rheumatoid arthritis
D E Furst
Pharmacotherapy
|
September 1, 1983
Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis
D E Furst
The Journal of Rheumatology. Supplement
|
October 1, 1988
Clinically important interactions of nonsteroidal antiinflammatory drugs with other medications
D E Furst
Page
of 76